Cost-effectiveness analysis shows that early invasive strategies are best for the treatment of unstable angina and non-ST segment elevated myocardial infarction (MI), according to a report in the Oct. 16 issue of The Journal of the American Medical Association.
“Overall, we found the cost-effectiveness of the invasive strategy ranging from $8,371 to $25,538 per year of life gained, estimates that are favorable compared to other treatments used in current medical practice,” lead author Elizabeth Mahoney, PhD, from the Emory University School of Medicine in Atlanta, Georgia, says in a news release.
“Now we have evidence that early, aggressive and initially more expensive treatment of these patients is actually very cost-effective over time. This is good news for these patients and their physicians because aggressive treatment offers the best prognosis.”
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!